Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Perrigo Company plc PRGO
$35.08
-$0.42 (-1.18%)
На 18:00, 12 мая 2023
+45.38%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
4812582295.00000000
-
week52high
43.90
-
week52low
30.78
-
Revenue
4451600000
-
P/E TTM
-37
-
Beta
0.80000000
-
EPS
-0.97000000
-
Last Dividend
1.09000000
-
Next Earnings Date
09 мая 2023 г. в 07:30
Описание компании
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Raymond James | Outperform | Outperform | 04 мая 2022 г. |
| Raymond James | Outperform | Outperform | 11 ноя 2021 г. |
| Raymond James | Outperform | Market Perform | 14 окт 2021 г. |
| Jefferies | Buy | Hold | 30 сент 2021 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 05 мар 2021 г. |
| Argus Research | Buy | Hold | 14 сент 2022 г. |
| Wells Fargo | Overweight | Equal-Weight | 06 сент 2022 г. |
| Raymond James | Outperform | Outperform | 09 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Quinn Grainne | D | 9118 | 2368 | 16 дек 2022 г. |
| Ives Alison | D | 738 | 739 | 07 окт 2022 г. |
| Ives Alison | D | 4756 | 217 | 07 окт 2022 г. |
| Ives Alison | A | 4973 | 739 | 07 окт 2022 г. |
| Manzone Albert | A | 5478 | 5478 | 15 авг 2022 г. |
| Ives Alison | A | 2759 | 2759 | 08 июл 2022 г. |
| Bezerra Eduardo Guarita | A | 13595 | 13595 | 07 июн 2022 г. |
| Doyle Katherine C. | D | 0 | 6599 | 17 мая 2022 г. |
| Doyle Katherine C. | D | 7778 | 7778 | 17 мая 2022 г. |
| Doyle Katherine C. | D | 6362 | 3168 | 17 мая 2022 г. |
Новостная лента
2 Pharma Stocks in Focus on FDA Buzz
Schaeffers Research
11 мая 2023 г. в 10:55
Immunitybio Inc (NASDAQ:IBRX) stock is crumbling today, down 52.1% at $2.98 at last glance, and earlier as low as $2.45, after the U.S. Food and Drug Administration (FDA) declined to approve its bladder cancer therapy.
Perrigo stock rises amid FDA's unanimous vote on over-the-counter birth control pill
Yahoo Finance
10 мая 2023 г. в 17:26
Yahoo Finance healthcare reporter Anjalee Khemlani joins the Live Show to discuss the rise of Perrigo stock after the FDA votes unanimously for over-the-counter access to the birth control pill.
FDA committee votes in favor of over-the-counter birth control pill
Market Watch
10 мая 2023 г. в 13:53
U.S. Food and Drug Administration advisory committees meeting jointly on Wednesday voted unanimously that the benefits of making Opill, a birth control pill, available for use without a prescription would outweigh the risks, drugmaker Perrigo Co. PLC PRGO said in a release. The joint committee's vote is not binding, but the FDA often follows advisory committee recommendations.
Perrigo (PRGO) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
09 мая 2023 г. в 12:13
The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Perrigo (PRGO) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research
09 мая 2023 г. в 09:10
Perrigo (PRGO) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.33 per share a year ago.